|Building Area Net||
Jones Lang LaSalle, Inc. (“JLL”), as exclusive representative for the Seller, is pleased to present this offering for the sale of the Mid-Atlantic Life Science Portfolio (the “Portfolio” or the “Properties”), consisting of four assets, totaling 450,241 RSF, in three of the top life science clusters in the nation. Comprised of three 100% leased assets with 8.2 years WALT, and one value-add 258,754 RSF life science campus, the Portfolio represents immediate scale in the life science industry. The Portfolio is comprised of high-quality lab, office, and biotech/pharmaceutical manufacturing space anchored by outstanding tenancy situated in the core life science markets of Philadelphia, New Jersey, and metro New York.
Offers will be accepted on a portfolio, sub-portfolio, and/or single asset basis.
- Three fully occupied, single tenant assets leased to proven life science companies with 8.2 years WALT
- Immediate, scalable exposure to the life science industry
- Four asset portfolio strategically located in some of the nation’s most preeminent life science clusters
- Mission critical locations serving unique collaborative functions and/or as headquarters locations